Connection

Gunnar Gislason to Drug Monitoring

Back to Details
This is a "connection" page, showing publications Gunnar Gislason has written about Drug Monitoring.
Gunnar Gislason
Connection Strength
0.027
Drug Monitoring
  1. The importance of time in therapeutic range in switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulants in atrial fibrillation. Europace. 2019 Apr 01; 21(4):572-580.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.